Monte Rosa Therapeutics Inc. (GLUE)
Drugs • Health Care
Percentage
Change
| Mar 22 | Mar 23 | Mar 24 | Mar 25 | Mar 26 | |
|---|---|---|---|---|---|
Net Income to Common | -73 | -39 | |||
Net Income | -73 | -39 | |||
Profit | -73 | -39 | |||
Net Income Continuing | -73 | -39 | |||
Income Tax Expense | -3 | 1 | |||
Pretax Income | -70 | -40 | |||
Total Non-operating Income | 11 | 14 | |||
Operating Income | -81 | -54 | |||
Total Revenue | 76 | 124 | |||
Total Costs and Expenses | -157 | -178 | |||
Operating Expenses | -157 | -178 | |||
Research and Development Expenses | -122 | -142 | |||
Selling, General & Administrative Expenses | -35 | -36 |